Triglyceride-rich lipoproteins prevent septic death in rats.
Open Access
- 1 July 1995
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 182 (1) , 267-272
- https://doi.org/10.1084/jem.182.1.267
Abstract
Triglyceride-rich lipoproteins bind and inactive bacterial endotoxin in vitro and prevent death when given before a lethal dose of endotoxin in animals. However, lipoproteins have not yet been demonstrated to improve survival in polymicrobial gram-negative sepsis. We therefore tested the ability of triglyceride-rich lipoproteins to prevent death after cecal ligation and puncture (CLP) in rats. Animals were given bolus infusions of either chylomicrons (1 g triglyceride/kg per 4 h) or an equal volume of saline for 28 h after CLP. Chylomicron infusions significantly improved survival (measured at 96 h) compared with saline controls (80 vs 27%, P < or = 0.03). Chylomicron infusions also reduced serum levels of endotoxin, measured 90 min (26 +/- 3 vs 136 +/- 51 pg/ml, mean +/- SEM, P < or = 0.03) and 6 h (121 +/- 54 vs 1,026 +/- 459 pg/ml, P < or = 0.05) after CLP. The reduction in serum endotoxin correlated with a reduction in serum tumor necrosis factor, measured 6 h after CLP (0 +/- 0 vs 58 +/- 24 pg/ml, P < or = 0.03), suggesting that chylomicrons improve survival in this model by limiting macrophage exposure to endotoxin and thereby reducing secretion of inflammatory cytokines. Infusions of a synthetic triglyceride-rich lipid emulsion (Intralipid; KabiVitrum, Inc., Alameda, CA) (1 g triglyceride/kg) also significantly improved survival compared with saline controls (71 vs 27%, P < or = 0.03). These data demonstrate that triglyceride-rich lipoproteins can protect animals from lethal polymicrobial gram-negative sepsis.Keywords
This publication has 38 references indexed in Scilit:
- Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.Journal of Clinical Investigation, 1990
- SEARCH FOR MEDIATORS OF THE LIPOGENIC EFFECTS OF TUMOR-NECROSIS-FACTOR - POTENTIAL ROLE FOR INTERLEUKIN-61990
- A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytesJournal of Immunological Methods, 1986
- Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.Proceedings of the National Academy of Sciences, 1986
- Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro.The Journal of cell biology, 1986
- An improved chromogenic substrate endotoxin assay for clinical use.Journal of Clinical Pathology, 1983
- Sepsis and septic shock—A review of laboratory models and a proposalJournal of Surgical Research, 1980
- The Clearance, Tissue Distribution, and Cellular Localization of Intravenously Injected Lipopolysaccharide in RabbitsThe Journal of Immunology, 1979
- Identification of the trypanocidal factor in normal human serum: high density lipoprotein.Proceedings of the National Academy of Sciences, 1978
- THE METABOLISM OF CHYLOMICRON CHOLESTERYL ESTER IN RAT LIVERThe Journal of cell biology, 1969